1315 Capital Backs USpharma Ltd. with Growth Equity Investment
June 30, 2025
USpharma Ltd., a Miami Lakes-based pharmaceutical development and manufacturing company, received a growth equity investment from Philadelphia-based 1315 Capital. The capital will be used to accelerate development and commercialization of USpharma’s pipeline, expand commercial reach, and scale operations at its 150,000 sq. ft. US-based GMP facility.
- Buyers
- 1315 Capital
- Targets
- USpharma Ltd.
- Industry
- Pharmaceuticals
- Location
- Florida, United States
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.